We report a solvent-free synthesis of novel 1,3,4,5-tetrasubstituted pyrazoles and investigate their inhibitory activity against soybean 15-lipoxygenase. It was revealed that all synthesized compounds exhibited good activity, and among them, 3-(furan-2-yl)-1,4,5-triphenyl-1H-pyrazole (5j) showed 10 times stronger inhibitory activity in comparison to the reference drug quercetin.
Introduction
Pyrazoles and polysubstituted pyrazoles are among the most valuable cores that belong to N-containing fivemembered heterocycles [1] [2] [3] [4] . Substituted pyrazoles exist as a central core in celecoxib [5] and sildenafil [6] used in market for the treatment of the pain and inflammation of osteoarthritis and erectile dysfunction and pulmonary arterial hypertension, respectively (Fig. 1 ). In addition, pyrazole derivatives have shown a broad range of properties from acting as optical sensors [7] [8] [9] and UV stabilizers [10] to different bioactivities including kinase inhibitor [11] , estrogen receptor agonists [12, 13] , cyclooxygenase-2 inhibitors [14] , HIV-1 reverse transcriptase inhibitors [15] , corticotropin-releasing factor (CRF-1) receptor antagonist [16] , and cannabinoid type 1 (CB1) receptor ligand [17] .
Pyrazole derivatives can be approached on different routes, such as the reaction of 1-carbamoyl and 1-oximyl cyclopropanes under Vilsmeier conditions [18] , acetic acidcatalyzed cyclocondensation of β-oxodithioester, amine, and hydrazine [19] , (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO)-mediated reaction of hydrazones [20] , a cycloaddition reaction of 2,3-disubstituted thiirane dioxides and benzonitrilium N-phenylimide [21] , trifluoroacetic acid (TFA)-catalyzed cycloaddition reaction of hydrazones with β-bromo-or β-chloro-β-nitrostyrenes [22] , and the reaction between N-monosubstituted hydrazones and nitroolefins [23] . In contrast, the number of methods devoted to the synthesis of tetraaryl-pyrazoles is limited [24] [25] [26] [27] [28] [29] [30] . Therefore, the development of novel derivatives of pyrazoles and evaluation of their bioactivities have found a special place in the drug discovery applications.
Herein, in continuation of our findings on the synthesis of bioactive heterocycles [31] [32] [33] [34] [35] [36] [37] [38] , we would like to report the synthesis of novel 1,3,4,5-tetrasubstituted pyrazoles from commercially available starting materials. These compounds could be regarded as promising candidates for lipoxygenase (LOX) inhibitors with regard to previous reports [39, 40] . LOX are non-heme iron-containing enzymes responsible for the oxidation of fatty acids and esters [41] , subdivided into different types (5-, 12-, and 15-LOX) [42] . The involvement of this enzyme in various diseases highlights the role of designing new selective inhibitors for medicinal chemists. With this attribute in mind, we investigated the activity of synthesized compounds 5a-k against soybean 15-LOX, exhibiting promising results.
Results and discussion

Chemistry
Tetrasubstituted pyrazoles 5a-k were prepared by generating phenyl hydrazone 3 from the condensation reaction between benzoin 1 and phenyl hydrazine 2. This reaction was known in the literature [43] [44] [45] . Therefore, according to Gnichtel's report [28] , further cyclization with aryl and heteroaryl aldehydes (RCHO) 4a-k at 150°C gave pyrazole derivatives 5a-k in good yields after recrystallization from ethanol (Scheme 1).
Pharmacology
15-LOX inhibitory activity
All the synthesized compounds containing aryl and heteroaryl substituents are promising inhibitors due to IC 50 values lower than the reference compound, quercetin. The IC 50 values at 20 µm are presented in Table 1 . The presence of electron donating groups such as OH, OMe, and Me groups at any positions and unsubstituted derivative 5a led to decreased activities. The introduction of electronwithdrawing groups such as fluoro (5f, 5g) and chloro substituents (5h, 5i) at ortho and para positions had a positive effect on the inhibitory activity. By employing heteroarylsubstituted aldehydes (5j, 5k) better results were obtained compared with unsubstituted and electron-rich derivatives. Among the tested compounds, 2-furyl derivative 5j is the most potent compound, displaying 10 times more activity (IC 50 = 5.2 ± 0.5 µm) than that of the reference compound. The replacement of 2-furyl with 2-thienyl resulted in three times loss in potency (IC 50 = 15.5 ± 1.1 µm). It can be concluded that stronger electron-withdrawing groups (fluorine versus chlorine and furyl versus thienyl) resulted in more active compounds, 5g and 5j, respectively.
Conclusions
In summary, we have described a short synthesis of tetrasubstituted pyrazoles from commercially available starting materials. The key cyclization reaction proceeded in 30 min and afforded the desired products in good yields, without the need for tedious work-up procedures. This finding will help to find more selective 15-LOX inhibitors, due to their significant role in the progression of Alzheimer's disease. 
Experimental section 4.1 15-LOX inhibition assay
Procedure for the synthesis of compound 3
Benzoin 1 (10 g, 0.037 mol) and phenyl hydrazine 2 (4.0 g, 0.047 mol) were heated at 120°C for 1 h, under the solventfree condition. The mixture was allowed to cool down; then, ethanol (50 mL) was added and the precipitate was collected and recrystallized from ethanol to give compound 3 (12.42 g, 87%).
Procedure for the synthesis of compounds 5a-k
A mixture of benzoin phenyl hydrazone 3 (0.5 g, 1.6 mmol) and benzaldehyde derivatives 4a-k was heated and stirred at 150°C for 30 min. After cooling down, diethyl ether (5 mL) was added and the resultant solid was purified by recrystallization from ethanol. 3059, 1597, 1523, 1495, 1451, 1395, 1323, 1287 Furan-2-yl)-1,4,5-triphenyl-1H- 
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Supplementary information
Copies of the 1 H NMR and 13 C NMR spectra of selected compounds are given as Supplementary Information available online (DOI: 10.1515/znb-2016-0092).
